litlas
Log inCreate account

Brian J. Nickoloff

Active 1984–2025

118
Papers
24,794
Citations
94
h-index
117
i10-index

Citations

Citations per year for Brian J. Nickoloff1985: 1 citations1986: 8 citations1987: 7 citations1988: 13 citations1989: 46 citations1990: 52 citations1991: 67 citations1992: 44 citations1993: 67 citations1994: 73 citations1995: 79 citations1996: 99 citations1997: 102 citations1998: 123 citations1999: 141 citations2000: 165 citations2001: 150 citations2002: 176 citations2003: 176 citations2004: 212 citations2005: 210 citations2006: 242 citations2007: 282 citations2008: 263 citations2009: 255 citations2010: 253 citations2011: 240 citations2012: 214 citations2013: 222 citations2014: 183 citations2015: 144 citations2016: 164 citations2017: 185 citations2018: 202 citations2019: 509 citations2020: 587 citations2021: 602 citations2022: 416 citations2023: 240 citations2024: 331 citations2025: 146 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,910 citing papers, 30.7% of this breakdownChina: 682 citing papers, 7.2% of this breakdownUnited Kingdom: 680 citing papers, 7.2% of this breakdownGermany: 667 citing papers, 7% of this breakdownItaly: 443 citing papers, 4.7% of this breakdownJapan: 436 citing papers, 4.6% of this breakdownFrance: 364 citing papers, 3.8% of this breakdownCanada: 350 citing papers, 3.7% of this breakdownSwitzerland: 224 citing papers, 2.4% of this breakdownAustralia: 208 citing papers, 2.2% of this breakdownNetherlands: 197 citing papers, 2.1% of this breakdownSpain: 188 citing papers, 2% of this breakdown
0%30.7%Other 22.4%

Institutions

Fields

  • Medicine43.4%
  • Immunology and Microbiology27.4%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Pharmacology, Toxicology and Pharmaceutics1.7%
  • Neuroscience1.2%
  • Dentistry0.6%
  • Other2.2%

Topics

  • Psoriasis: Treatment and Pathogenesis7.5%
  • Dermatology and Skin Diseases7.2%
  • T-cell and B-cell Immunology2.7%
  • Immunotherapy and Immune Responses2.6%
  • Immune Cell Function and Interaction2%
  • Asthma and respiratory diseases1.8%
  • Other76.2%

Coauthors

All papers

Open in search
  1. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

    Authors: Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi - New England Journal of Medicine 2016 cited by 838

  2. Skin immune sentinels in health and disease

    Authors: Frank O. Nestlé, Paola Di Meglio, Jian‐Zhong Qin, Brian J. Nickoloff - Nature reviews. Immunology 2009 cited by 1,379

  3. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

    Authors: C.E.M. Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, C. Paul, Alan Menter, Gregory S. Cameron, J. Erickson, Lu Zhang, Roberta J. Secrest, Susan Ball, Daniel Braun, Olawale Osuntokun, Michael Heffernan, Brian J. Nickoloff, Kim Papp - The Lancet 2015 cited by 831

  4. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

    Authors: Shigetoshi Sano, Keith Syson Chan, Steve Carbajal, John L. Clifford, Mary Peavey, Kaoru Kiguchi, Satoshi Itami, Brian J. Nickoloff, John DiGiovanni - Nature Medicine 2004 cited by 747

  5. Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α

    Authors: Onur Boyman, Hans Peter Hefti, Curdin Conrad, Brian J. Nickoloff, Mark Suter, Frank O. Nestlé - The Journal of Experimental Medicine 2004 cited by 514

  6. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

    Authors: Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield, Emma Guttman‐Yassky, Brett King, Jonathan I. Silverberg, Lisa A. Beck, Thomas Bieber, Kristian Reich, Kenji Kabashima, Marieke M.B. Seyger, Elaine C. Siegfried, Georg Stingl, Steven R. Feldman, Alan Menter, Peter van de Kerkhof, Gil Yosipovitch, C. Paul, Philippe Martel, Ariane Dubost-Brama, John Armstrong, Rajeev Chavda, Steve Frey, Y. Joubert, M. Milutinovic, Anne Parneix, Henrique D. Teixeira, Chen-Yen Lin, Luna Sun, Paul Klekotka, Brian J. Nickoloff, Yves Dutronc, Lotus Mallbris, Jonathan Janes, Amy M. DeLozier, Fabio P. Nunes, Amy S. Paller - Journal of the American Academy of Dermatology 2020 cited by 178

  7. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

    Authors: Emma Guttman‐Yassky, Jonathan I. Silverberg, Osamu Nemoto, Seth Forman, A Wilke, Randy Prescilla, Amparo de la Peña, Fabio P. Nunes, Jonathan Janes, Margaret Gamalo, David W. Donley, Jim S Paik, Amy M. DeLozier, Brian J. Nickoloff, Eric L. Simpson - Journal of the American Academy of Dermatology 2018 cited by 311

  8. Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack

    Authors: Taisuke Ito, Natsuho Ito, Matthias Saatoff, Hideo Hashizume, Hidekazu Fukamizu, Brian J. Nickoloff, Masahiro Takigawa, Ralf Paus - Journal of Investigative Dermatology 2007 cited by 297

  9. Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

    Authors: Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J. Richardson, Vanessa Monteil, Volker M. Lauschke, Alì Mirazimi, Sonia Youhanna, Yee‐Joo Tan, Fausto Baldanti, Antonella Sarasini, Jorge Alfonso Ross Terres, Brian J. Nickoloff, Richard E. Higgs, Guilherme Rocha, Nicole L Byers, Douglas Schlichting, Ajay Nirula, Anabela Cardoso, Mario Corbellino, the Sacco Baricitinib Study Group - EMBO Molecular Medicine 2020 cited by 272

  10. Assessment and Clinical Relevance of Serum IL-19 Levels in Psoriasis and Atopic Dermatitis Using a Sensitive and Specific Novel Immunoassay

    Authors: Robert J. Konrad, Richard E. Higgs, George H. Rodgers, Wenyu Ming, Yuewei Qian, Nicoletta Bivi, Justin K. Mack, Robert W. Siegel, Brian J. Nickoloff - Scientific Reports 2019 cited by 59

  11. Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

    Authors: Paola Rizzo, Haixi Miao, Gwendolyn D'Souza, Clodia Osipo, Jieun Yun, Huiping Zhao, Joaquina Mascarenhas, Debra Wyatt, Giovanni Antico, Lu Hao, Katharine Yao, Prabha Rajan, Chindo Hicks, Kalliopi P. Siziopikou, Suzanne M. Selvaggi, Amina Bashir, Deepali Bhandari, Adriano Marchese, Urban Lendahl, Jian‐Zhong Qin, Debra A. Tonetti, Kathy S. Albain, Brian J. Nickoloff, Lucio Miele - Cancer Research 2008 cited by 340

  12. Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells

    Authors: Jian‐Zhong Qin, Jeffrey Ziffra, Lawrence Stennett, Barbara Bodner, Brian K. Bonish, Vijaya Chaturvedi, Frank Bennett, Pamela M. Pollock, Jeffrey M. Trent, Mary J.C. Hendrix, Paola Rizzo, Lucio Miele, Brian J. Nickoloff - Cancer Research 2005 cited by 338

  13. 4-Tertiary Butyl Phenol Exposure Sensitizes Human Melanocytes to Dendritic Cell-Mediated Killing: Relevance to Vitiligo

    Authors: Tara M. Kroll, Hemamalini Bommiasamy, Raymond E. Boissy, Claudia Hernandez, Brian J. Nickoloff, Ruben Mestril, I. Caroline Le Poole - Journal of Investigative Dermatology 2005 cited by 167

  14. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19

    Authors: Jonathan T. Sims, Venkatesh Krishnan, Ching-Yun Chang, Sarah Engle, Giacomo Casalini, George H. Rodgers, Nicoletta Bivi, Brian J. Nickoloff, Robert J. Konrad, Stephanie de Bono, Richard E. Higgs, Robert J. Benschop, Silvia Ottaviani, Anabela Cardoso, Ajay Nirula, Mario Corbellino, Justin Stebbing - Journal of Allergy and Clinical Immunology 2020 cited by 173

  15. The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition

    Authors: Samudra K. Dissanayake, Michael S. Wade, Carrie E. Johnson, Michael P. O’Connell, Poloko D. Leotlela, Amanda D. French, Kavita V. Shah, Kyle J. Hewitt, Devin T. Rosenthal, Fred E. Indig, Yuan Jiang, Brian J. Nickoloff, Dennis D. Taub, Jeffrey M. Trent, Randall T. Moon, Michael Bittner, Ashani T. Weeraratna - Journal of Biological Chemistry 2007 cited by 368

  16. Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis

    Authors: Ute Laggner, Paola Di Meglio, Gayathri Perera, Christian Hundhausen, Katie E. Lacy, Niwa Ali, Catherine Smith, Adrian Hayday, Brian J. Nickoloff, Frank O. Nestlé - The Journal of Immunology 2011 cited by 319

  17. Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis

    Authors: G Tonel, Curdin Conrad, Ute Laggner, Paola Di Meglio, Katarzyna Grys, Terrill K. McClanahan, Wendy M. Blumenschein, Jian‐Zhong Qin, Hong Xin, Elizabeth R. Oldham, Robert Kastelein, Brian J. Nickoloff, Frank O. Nestlé - The Journal of Immunology 2010 cited by 223

  18. Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability

    Authors: Guang Yang, Yitang Li, Emi K. Nishimura, Hong Xin, Anyu Zhou, Yinshi Guo, Liang Dong, Mitchell F. Denning, Brian J. Nickoloff, Rutao Cui - Molecular Cell 2008 cited by 141

  19. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin

    Authors: Brian J. Nickoloff, Yathi M. Naidu - Journal of the American Academy of Dermatology 1994 cited by 459

  20. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness

    Authors: Jolanta M. Topczewska, Lynne‐Marie Postovit, Naira V. Margaryan, Anthony Sam, Angela R. Hess, William W. Wheaton, Brian J. Nickoloff, Jacek Topczewski, Mary J.C. Hendrix - Nature Medicine 2006 cited by 442

  21. Overexpression of Akt converts radial growth melanoma to vertical growth melanoma

    Authors: Baskaran Govindarajan, James E. Sligh, Bethaney Vincent, Meiling Li, Jeffrey A. Canter, Brian J. Nickoloff, Richard J. Rodenburg, Jan Smeıtınk, Larry W. Oberley, Yuping Zhang, Joyce M. Slingerland, Rebecca S. Arnold, J. David Lambeth, C. M. S. Cohen, Lu Hilenski, Kathy K. Griendling, Marta Martínez, José M. Cuezva, Jack L. Arbiser - Journal of Clinical Investigation 2007 cited by 272

  22. Contoversies in Experimental Dermatology

    Authors: Cheng‐Ming Chuong, Brian J. Nickoloff, Peter M. Elias, Lowell A. Goldsmith, E Macher, P A Maderson, John P. Sundberg, Hachiro Tagami, Przemysław M. Płonka, K Thestrup-Pederson, Bruno Bernard, Jens‐Michael Schröder, Paolo Dotto, C. M. Chang, Mary L. Williams, Kenneth R. Feingold, Lloyd E. King, Albert M. Kligman, Jonathan L. Rees, Enno Christophers - Experimental Dermatology 2002 cited by 263

  23. Focal Adhesion Kinase Promotes the Aggressive Melanoma Phenotype

    Authors: Angela R. Hess, Lynne‐Marie Postovit, Naira V. Margaryan, Elisabeth A. Seftor, Galen B. Schneider, Richard E.B. Seftor, Brian J. Nickoloff, Mary J.C. Hendrix - Cancer Research 2005 cited by 154

  24. Notch Signaling Regulates Mouse and Human Th17 Differentiation

    Authors: Shilpa Keerthivasan, Reem Suleiman, Rebecca Lawlor, Justine E. Roderick, Tonya C. Bates, Lisa M. Minter, Juan Anguíta, Ignacio J. Juncadella, Brian J. Nickoloff, I. Caroline Le Poole, Lucio Miele, Barbara A. Osborne - The Journal of Immunology 2011 cited by 145